%0 Journal Article
%A Liras, Antonio
%A García-Tenchard, Rebecca
%T Treatment for hemophilia: recombinant versus plasma-derived coagulationfactors – controversy and debateforever? An ethical medical challenge?
%D 2013
%@ 1747-4086,  1747-4094 (ESSN)
%U https://hdl.handle.net/20.500.14352/34703
%X With the eradication of infection by HIV and hepatitis C virus that were common just a few years ago, the most concerning adverse effect resulting from the use of both recombinant and plasma-derived products is the appearance of antibodies (inhibitors) to perfused exogenous factors.”
%~